£3.6bn pay-out in tal­cum case


WOMEN should avoid us­ing tal­cum pow­der on their gen­i­tals due to it pos­ing an in­creased risk of ovar­ian cancer, a UK char­ity has warned af­ter a phar­ma­ceu­ti­cal gi­ant was hit by a mas­sive pay­out af­ter le­gal ac­tion in the US.

John­son & John­son has been or­dered to pay £3.6 bil­lion to a group of 22 women who al­lege the com­pany’s tal­cum pow­ders caused ovar­ian cancer.

Tar­get Ovar­ian Cancer said it was im­por­tant to note that the in­creased risk was “very small”.

Re­becca Rennison, di­rec­tor of pub­lic af­fairs and ser­vices, said: “Var­i­ous stud­ies have shown a link between us­ing tal­cum pow­der between the legs and ovar­ian cancer. We would gen­er­ally ad­vise against us­ing tal­cum on this area of the body.”

The af­fected women claimed John­son & John­son’s Baby Pow­der and Shower to Shower prod­ucts were laced with cancer-caus­ing as­bestos “for decades”. The firm is to ap­peal the ver­dict.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.